Freestone Capital Holdings’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.02M | Buy |
|
|||||
|
2025
Q2 | $2.6M | Buy |
|
|||||
|
2025
Q1 | $1.54M | Sell |
|
|||||
|
2024
Q4 | $1.77M | Buy |
|
|||||
|
2024
Q3 | $1.28M | Buy |
|
|||||
|
2024
Q2 | $1.71M | Buy |
|
|||||
|
2024
Q1 | $1.97M | Buy |
|
|||||
|
2023
Q4 | $1.69M | Buy |
|
|||||
|
2023
Q3 | $1.23M | Buy |
|
|||||
|
2023
Q2 | $1.31M | Buy |
|
|||||
|
2023
Q1 | $1.17M | Sell |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $834K | Sell |
|
|||||
|
2022
Q2 | $818K | Sell |
|
|||||
|
2022
Q1 | $1.56M | Buy |
|
|||||
|
2021
Q4 | $923K | Buy |
|
|||||
|
2021
Q3 | $778K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $42.5K | Buy |
|
|||||
|
2020
Q3 | $24.3K | Buy |
|